Nitric oxide participates in the immune response against Neisseria meningitidis serogroup B

FEMS Immunology and Medical Microbiology

Volumn 25, Issue 4, 1999, Pages 385-389

  Padrón, Julio ^a   Bebelagua, Yanín ^a   Lastre, Miriam ^a   Lapinet, José ^a   Zayas, Caridad ^a   Quintero, Yanet ^a   Diaz, Miriam ^a   Pérez, Oliver ^a  

^a Res Div Dept Immunol Finlay I   (Cuba)

Author keywords

Immune response; Neisseria meningitidis; Nitric oxide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; MENINGOCOCCUS VACCINE; N(G) METHYLARGININE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VA MENGOC BC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE RELEASE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ANIMALS; BACTERIAL VACCINES; ENZYME INHIBITORS; HUMANS; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; MICE; NEISSERIA MENINGITIDIS; NITRIC OXIDE; OMEGA-N-METHYLARGININE; POLYSACCHARIDES, BACTERIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032792449     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00113-3     Document Type: Article

References (23)

1. Hoen B. Epidemiology of primary bacterial meningitis. Rev. Prat. 44:1994;2148-2151.
2. Kornelisse R.F., Hazelzet J.A., Hop W.C., Spanjaard L., Suur M.H., Van der Voort E., de Groot R. Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin. Infect. Dis. 25:1997;640-646.
3. Nishijima H., Weil M.H., Shubia H., Canilles J. Hemodynamic and metabolic studies on shock associated with gram negative bacteremia. Medicine. 52:1973;287-294.
4. Cerami A., Ikeda Y., Le Trang N., Hotez P., Beutler B. Weight loss associated with an endotoxin induced mediator from peritoneal macrophages; the role of cachectin (tumour necrosis factor). Immunol. Lett. 11:1985;173-177.
5. Kilbourn R.G., Jubran A., Gross S.S. Reversal of endotoxin-mediated shock by NG-Methyl L-Arginine, an inhibitor of NO Synthesis. Biochem. Biophys. Res. Commun. 172:1990;1132-1138.
6. De-Groote M.A., Fang F.C. Nitric oxide inhibitors: antimicrobial properties of NO. Clin. Infect. Dis. 2:1995;162-165.
7. Lucey D.R., Clerici M., Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin. Microbiol. Rev. 9:1996;532-562.
8. Nabors G.S., Afonso L.C., Farrell J.P., Scott P. Switch from a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin-12 and Pentostam. Proc. Natl. Acad. Sci. USA. 92:1995;3142-3146.
9. Johnson K., Aarden L., Choi Y., De-Groot E., Creasey A. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood. 87:1996;5051-5060.
10. Rojas A., Padron J., Caveda L., Palacios M., Moncada S. Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharides. Biochem. Biophys. Res. Commun. 191:1993;441-446.
11. Singh A.P., Khuller G.K. Induction of immunity against experimental tuberculosis with mycobacterial mannophospho-inositides encapsulated in liposomes containing lipid A. FEMS Immunol. Med. Microbiol. 8:1994;119-126.
12. Rojas A., Caveda L., Romay C., Lopez E., Valdes S., Padron J., Glaria L., Martinez O., Delgado R. Effect of advanced glycosylation end products on the induction of NOS in murine macrophages. Biochem. Biophys. Res. Commun. 225:1996;358-362.
13. Sifontes S., Infante J.F., Perez P., Caro E., Sierra G., Campa C. The hyperferremic mouse model for the evaluation of the effectiveness of VA-MENGOC-BC against Neisseria meningitidis B clinical isolates. Arch. Med. Res. 28:1997;41-45.
14. Padron J., Glaria L., Martinez O., Torres M., López E., Delgado R., Caveda L., Rojas A. Nitric oxide modulates interleukin-2 induced proliferation in CTLL-2 cells. Mediat. Inflamm. 5:1996;324-327.
15. Zinetti M., Fantuzzi G., Delgado R. Endogenous nitric oxide production by human monocyte cells regulates LPS-induced TNF production. Eur. Cytokine Netw. 6:1995;45-48.
16. Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y.M., Dietzschold B., Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA. 93:1996;2448-2453.
17. Noronha C.P., Struchiner C.J., Halloran M.E. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. Int. J. Epidemiol. 24:1995;1050-1057.
18. Nathan C. Perspectives series: What difference does it make. J. Clin. Invest. 100:1997;2417-2423.
19. Phillips N.C., Gagne L. Modulation of murine macrophages NO synthesis by liposomal phospholipids: correlation with liposome immune adjuvant activity. J. Drug Target. 3:1995;137-147.
20. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., Phillips R.S. Regulation of the immune response by NO differentially produced by T helper type 1 and type 2 cells. Eur. J. Immunol. 24:1994;980-984.
21. Milagres L.G., Ramos S.R., Sacchi C.T. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:1994;4419-4424.
22. Kornelisse R.F., Hack C.E., Savelkoul H.F., van der Pouw-Kraan T.C., Hop W.C., van Mierlo G., Suur M.H., Neijens H.J., de Groot R. Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect. Immun. 65:1997;877-881.
23. Kornelisse R.F., Hoekman K., Visser J.J., Hop W.C., Huijmans J.G., van der Straaten P.J., van der Heijden A.J., Sukhai R.N., Neijens H.J., de Groot R. The role of nitric oxide in bacterial meningitis in children. J. Infect. Dis. 174:1996;120-126.